Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to…
Stockholm, January 12th, 2022 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Markus Hökerberg as an interim Chief Financial Officer, effective 25th of January. He succeeds Ann-Charlotte Linderoth, who will take on the…
Stockholm, January 12th, 2022 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Markus Hökerberg as an interim Chief Financial Officer, effective 25th of January. He succeeds Ann-Charlotte Linderoth, who will take on the…
STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved that the subsidiary INIFY Laboratories will become an independent company…
STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved that the subsidiary INIFY Laboratories will become an independent company…
On the 10th of December 2021, ContextVision AB held an Extraordinary General Meeting in Stockholm. The Board's proposal for a resolution on dividend of all shares in the Company’s wholly-owned subsidiary INIFY Laboratories AB containing the line of business Digital…
On the 10th of December 2021, ContextVision AB held an Extraordinary General Meeting in Stockholm. The Board's proposal for a resolution on dividend of all shares in the Company’s wholly-owned subsidiary INIFY Laboratories AB containing the line of business Digital…